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Abstract
Background: ‘PACE Steps to Success’ is a multicomponent training program aiming to integrate generalist and
non-disease-specific palliative care in nursing homes. This program did not improve residents’ comfort in the last
week of life, but it appeared to improve quality of care and dying in their last month of life. Because this program
included only three dementia-specific elements, its effects might differ depending on the presence or stage of
dementia. We aimed to investigate whether the program effects differ between residents with advanced, non-
advanced, and no dementia.
Methods: Pre-planned subgroup analysis of the PACE cluster-randomized controlled trial in 78 nursing homes in
seven European countries. Participants included residents who died in the previous 4 months. The nursing home
staff or general practitioner assessed the presence of dementia; severity was determined using two highly-
discriminatory staff-reported instruments. Using after-death questionnaires, staff assessed comfort in the last week
of life (Comfort Assessment in Dying–End-of-Life in Dementia-scale; primary outcome) and quality of care and
dying in the last month of life (Quality of Dying in Long-Term Care scale; secondary outcome).
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Results: At baseline, we included 177 residents with advanced dementia, 126 with non-advanced dementia and
156 without dementia. Post-intervention, respectively in the control and the intervention group, we included 136
and 104 residents with advanced dementia, 167 and 110 with non-advanced dementia and 157 and 137 without
dementia. We found no subgroup differences on comfort in the last week of life, comparing advanced versus
without dementia (baseline-adjusted mean sub-group difference 2.1; p-value = 0.177), non-advanced versus without
dementia (2.7; p = 0.092), and advanced versus non-advanced dementia (− 0.6; p = 0.698); or on quality of care and
dying in the last month of life, comparing advanced and without dementia (− 0.6; p = 0.741), non-advanced and
without dementia (− 1.5; p = 0.428), and advanced and non-advanced dementia (0.9; p = 0.632).
Conclusions: The lack of subgroup difference suggests that while the program did not improve comfort in dying
residents with or without dementia, it appeared to equally improve quality of care and dying in the last month of
life for residents with dementia (regardless of the stage) and those without dementia. A generalist and non-disease-
specific palliative care program, such as PACE Steps to Success, is a useful starting point for future palliative care
improvement in nursing homes, but to effectively improve residents’ comfort, this program needs further
development.
Trial registration: ISRCTN, ISRCTN14741671. Registered 8 July 2015 – Retrospectively registered.
Keywords: Nursing home care, End of life care, Bereavement, Pain, Communication, Neurological conditions
Background
Between 14 and 29% of people aged 65 years and over in
many developed countries die in nursing homes [1].
However, the quality of dying and end-of-life care in this
setting, even in countries with high levels of palliative
care development, is sub-optimal [2, 3]. To contribute
high-quality evidence to address this problem, we devel-
oped ‘PACE Steps to Success’, which is a multicompo-
nent program aiming to integrate generalist and non-
disease-specific palliative care into nursing homes in six
steps using a train-the-trainer approach. Nursing home
staff are trained to deliver high-quality palliative care to
all residents, from advance care planning to care up to
and beyond death [4]. Between 2015 and 2017, we evalu-
ated this program in a seven-country cluster-
randomized controlled trial (RCT). The primary trial
analyses showed that ‘PACE Steps to Success’ did not
improve the comfort in the last week of life (primary
outcome) in the overall nursing home population, but it
appeared to improve quality of care and dying in the last
month of life for this population, although the latter was
the secondary outcome [5].
Because this program was designed for all residents
and included only three dementia-specific elements [4],
we hypothesized that its effects might differ between
those with and without dementia in favor of those with
mild/moderate or no dementia compared with advanced
dementia. People with dementia, especially those with
advanced dementia, have wide-ranging physical, cogni-
tive and behavioral impairments, which make their pal-
liative care needs distinct from those without dementia
[6, 7]. It is often assumed that for palliative care pro-
grams to be effective for people with dementia, they
should specifically address the needs of this population
[7–9]. Therefore, at the outset of the trial, we planned a
subgroup analysis using the same outcome measures as
in the primary trial analyses to test this hypothesis [10].
Understanding whether the program effects differ be-
tween people with and without dementia while taking
dementia severity into account could inform future de-
velopment of palliative care programs for nursing home
residents, of whom between 60 and 83% die with de-
mentia [11]. The present study aims to answer the re-
search question: “Do the effects of the PACE Steps to
Success program on comfort in the last week of life and
quality of care and dying in the last month of life differ
between residents with advanced, non-advanced and
without dementia?”
Methods
This is a pre-planned subgroup analysis of the PACE
cluster randomized controlled trial (see data analyses
plan submitted as an official deliverable to the European
Commission in Additional file 1) [4, 5, 10]. This cluster-
RCT was conducted in 78 nursing homes in Belgium,
England, Finland, Italy, the Netherlands, Poland and
Switzerland to compare PACE Steps to Success with
usual care (2015–2017). This trial was registered at
http://www.isrctn.com on July 30, 2015 (ISRC
TN14741671). Randomization was performed at the
nursing home level as the program involved the training
of nursing home staff. After baseline measurement,
randomization was stratified by country and median
number of beds in a 1:1 ratio. Randomization was
blinded and performed by independent statisticians. Be-
cause of the nature of the study, blinding of treatment
was not possible for researchers or participants. More
details about the PACE cluster-RCT have been
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published elsewhere [4, 5]. We reported this study fol-
lowing the CONSORT guidelines for randomized trials.
Program description
PACE Steps to Success was implemented over the
course of 1 year, including 2 months for preparation, 6
months training for nursing home staff in the six steps,
and 4 months consolidation. All countries had one or
more country trainers. Each nursing home assigned one
to six staff members as PACE coordinators. After being
trained by two experienced trainers, the country trainers
trained and supported the PACE coordinators who were
in turn responsible for training and supporting fellow
staff. The six PACE Steps included: 1) advance care
planning with residents and families; 2) assessment, care
planning, and review of resident needs and problems; 3)
coordination of care via monthly multidisciplinary pallia-
tive care review meetings; 4) high-quality palliative care
with a focus on pain and depression; 5) care in the last
days of life and 6) care after death [4]. The program in-
cluded three dementia-specific elements: communication
training in advanced dementia for the PACE coordina-
tors, and two elements integrated into the training for
all nursing home staff which emphasized dementia as a
terminal illness (as part of Step 2) and offered symptom
control strategies for residents with and without demen-
tia (in Step 4) [4, 5].
Participating nursing homes
From a list of nursing homes, those located in a prede-
fined country-specific geographical location were
approached randomly by telephone or e-mail to invite
them to participate in the study and to evaluate eligibil-
ity criteria using a standardized checklist. Inclusion cri-
teria were the provision of on-site nursing care and
personal assistance with activities of daily living and off-
site medical care by general practitioners (GPs), having
at least 30 beds, 15 or more residents having died in or
outside the nursing home in the previous year to obtain
sufficient power, consent to participation from manage-
ment in writing before randomization, and agreement to
allocate approximately 0.5 days per week for staff to act
as PACE coordinators. We excluded nursing homes that
had pilot-tested the program materials or used detailed
palliative care guidelines/planning tools, the Gold Stan-
dards Framework and InterRAI-PC [4, 5].
Data collection and respondents
One contact person per nursing home identified all resi-
dents who had died in the previous 4 months. After-
death structured questionnaires for each resident were
sent to the staff member most involved in care (prefera-
bly a nurse), nursing home administrator and GP at
baseline (month 0) and post-intervention (months 13
and 17). As sensitivity analyses showed no difference be-
tween program effects using the two post-intervention
data, these combined post-intervention data were used
in the primary analyses [5]. In this subgroup analysis, we
included residents for whom the presence and severity
of dementia was determined, classified into three sub-
groups: advanced, non-advanced and without dementia.
We deviated from our pre-planned subgroups (residents
with and without dementia), so that we could better in-
vestigate the difference between residents with advanced
and without dementia.
Measurements and outcomes
Nursing home staff and GP reported whether a resident
“had dementia” or “was diagnosed with dementia”. De-
mentia was considered present if at least one indicated it
was and not present when both indicated it was not or
when one indicated this but the other neither returned
the questionnaire nor answered the question. Dementia
severity was determined using two highly-discriminatory
staff-reported instruments, Cognitive Performance Scale
(CPS) and Global Deterioration Scale (GDS); those with
CPS scores of 5–6 and GDS stage 7 were classified as
having advanced dementia, the others as non-advanced
dementia. CPS classifies residents into six hierarchical
cognitive performance categories, with higher scores in-
dicating worse cognitive impairment [12]. GDS stage 7
indicates very severe cognitive and functional deterior-
ation [13].
Nursing home administrators reported a resident’s sex
and age at time of death. Staff assessed functional status
1 month before death in terms of dependency level with
eating, dressing and mobility using the Bedford Alzhei-
mer Nursing Severity-Scale: categorized into ‘independ-
ent’, ‘needs assistance’, or ‘fully dependent’ [14].
Primary outcome was staff-reported comfort in the last
week of life using the validated Comfort Assessment in
Dying–End-of-Life in Dementia (CAD-EOLD) scale; see
comprehensive description of outcomes in Add-
itional file 2 [15, 16]. CAD-EOLD comprises four sub-
scales: physical distress, dying symptoms, emotional
distress and well-being. The CAD-EOLD total scores
range between 14 and 42, with higher scores indicating
better comfort. CAD-EOLD was found to have better
psychometric properties and user-friendliness than other
comfort measures in a mixed nursing home population,
including residents with and without dementia [17–19].
Secondary outcome was staff-reported quality of care
and dying in the last month of life measured using the
validated Quality of Dying in Long Term Care (QOD-
LTC) scale, comprising ‘personhood’, ‘preparatory tasks’
and ‘closure’ subscales [20]. The QOD-LTC total scores
range between 11 and 55, with higher scores indicating
better quality of care and dying.
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Statistical analyses
Linear mixed models were used to analyze continuous
outcomes and account for the clustered nature of data,
with staff, nursing home and country as random factors
(only random intercepts) and group (intervention versus
usual care), time (post-intervention combining data col-
lected at months 13 and 17 versus baseline) and their
interaction as fixed factors. We analyzed differential ef-
fects by calculating differences in mean change (post-
intervention combining data collected at months 13 and
17 minus baseline) between the subgroups, both for the
intervention and control groups (interaction group*ti-
me*dementia). For the differential effects, we present es-
timated differences (and 95% Confidence Intervals) in
mean change between the subgroups. All hypothesis
testing was two-sided. P-values and 95% Confidence In-
tervals were not adjusted for multiple testing. To address
multiplicity concerns with Bonferroni correction, p-
values should be compared against a 1% significance
level to address multiplicity concerns examining demen-
tia subgroups [21]. In individual subgroups, we pre-
sented estimated mean scores and mean differences
between groups post-intervention. All analyses were on
an intention-to-treat and a complete-case basis, assum-
ing data were missing at random. All statistical analyses
were conducted using SAS 9.4 software (©SAS Institute
Inc., USA).
Results
Of the 160 nursing homes assessed for eligibility, 82
were excluded (43 were excluded as the required num-
ber of nursing homes were reached in the country and
39 did not meet the inclusion criteria) (Fig. 1). Of the 78
nursing homes randomized, 1 nursing home in the con-
trol group and 2 nursing homes in the intervention
group dropped out. Between the program implementa-
tion and the post-intervention measurements, 2 nursing
homes in the control group dropped out. At baseline, we
included 177 residents with advanced dementia, 126
with non-advanced dementia and 156 without dementia
(Fig. 1). In the control group post-intervention, we in-
cluded 136 residents with advanced dementia, 167 with
non-advanced dementia and 157 without dementia. In
the intervention group post-intervention, we included
104 residents with advanced dementia, 110 with non-
advanced dementia and 137 without dementia. We ex-
cluded 92 residents at baseline and 98 (control group)
and 75 (intervention group) residents post-intervention,
as the presence and severity of dementia could not be
determined.
Table 1 provides a detailed description of the charac-
teristics of the residents in the three subgroups for the
baseline and the post-intervention measurements. At
time of death, average age was between 82.5 and 87.5
years at baseline and between 84.0 and 86.9 years post-
intervention. They were predominantly female, with per-
centages ranging from 53.7 to 70.7% at baseline and
from 56.1 to 67.7% post-intervention. Between 73.3 and
97.8% of residents with advanced dementia were ADL-
(activities of daily living) dependent for eating, dressing
and mobility. Among those with non-advanced and no
dementia, between 42.4 and 71.4% were ADL-dependent
for dressing and mobility, while between 19.1 and 32.8%
were fully dependent for eating.
The program effects on comfort in the last week of life
did not differ statistically between residents with ad-
vanced and without dementia (subgroup differences in
baseline-adjusted mean differences 2.1; 95% CI − 0.9–
5.1; p = .177), those with non-advanced and without de-
mentia (2.7; − 0.4–5.9; p = .092), or those with advanced
and non-advanced dementia (− 0.6; − 3.8–2.5; p = .698)
(Table 2). The baseline-adjusted mean differences in
comfort scores were − 1.9 without dementia to 0.8 with
non-advanced dementia (Table 3).
The program effects on quality of care and dying in
the last month of life also did not differ statistically be-
tween advanced and no dementia (− 0.6; − 4.1–2.9; p =
.741), non-advanced and no dementia (− 1.5; − 5.2–2.2;
p = 0.428), or advanced and non-advanced dementia
(0.9; − 2.8–4.6; p = .632) (Table 2). The baseline-adjusted
mean differences in quality of care and dying scores
were 2.7 in non-advanced dementia to 4.2 in no demen-
tia (Table 3).
Discussion
This subgroup analysis showed that the effects of PACE
Steps to Success on comfort in the last week of life and
on quality of care and dying in the last month of life did
not differ between residents with advanced, non-
advanced and no dementia.
Using a subgroup analysis of a large pragmatic cluster-
RCT, this study offers insight on the effects of a general-
ist, non-disease-specific palliative care training program
designed to train nursing home staff to deliver high-
quality palliative care to nursing home residents with de-
mentia (advanced and non-advanced) and without de-
mentia [22]. We also included a large number of
residents for whom the severity of dementia was deter-
mined using validated instruments. Further, following
the formal rules for planning and analysis of subgroup
analysis, this subgroup analysis was pre-planned and
used statistical tests of interactions, which enhance the
validity of study results [21]. Nonetheless, because power
calculation was not conducted for this subgroup analysis,
our study might not have detected potentially important
but small subgroup difference in program effects. For in-
stance, although we found a 2.7 CAD-EOLD score point
difference between residents with non-advanced and no
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dementia, which is close to what we considered as a
clinically-important effect (i.e. CAD-EOLD score of 3
points) [4, 5], the limited power might not have allowed
us to detect statistically significant differences. In
addition, as the presence of dementia relied on the esti-
mation of the staff or the GP, there might be some mis-
classifications, particularly among residents with
difficult-to-observe mild dementia symptoms. Finally,
since data were collected after death, there might also be
some recall bias [4, 5].
Contrary to our hypothesis, this study showed that the
effects of the program did not differ between residents
with advanced, non-advanced and no dementia. For the
primary outcome – comfort in the last week of life – it
Fig. 1 Flowchart of the identification of subgroups at baseline and post-intervention. a Reasons for refusal included insufficient time, no interest,
understaffing, already involved in other studies, change in management. b Excluded in the subgroup analysis, because the presence and severity
of dementia could not be determined. c Pre-implementation phase (months 1–2), implementation phase (months 3–8), and consolidation phase
(months 9–12)
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Table 1 Characteristics of residents by subgroups
TOTAL SAMPLE FOR THE SUBGROUP ANAL
YSIS
Baseline scores (T0) Post-intervention (T1 + T2)
Control Intervention Control Intervention
N = 238 N = 221 N = 460 N = 351
Advanced dementia (n = 99) (n = 78) (n = 136) (n = 104)
Age at time of death, unadjusted mean (SD) 85.5 (7.3) 86.3 (8.6) 86.1 (8.0) 86.5 (8.3)
Gender, female, unadjusted frequency, n (%) 70 (70.7) 47 (60.3) 88 (64.7) 64 (61.5)
Eating dependencya, n (%)
- Independent 0 (0) 1 (1.3) 0 (0) 3 (2.9)
- Needs assistance 17 (17.3) 18 (23.4) 26 (19.1) 21 (20.4)
- Fully dependent 81 (82.7) 58 (73.3) 110 (80.9) 79 (76.7)
Dressing dependencya, n (%)
- Independent 0 (0) 0 (0) 0 (0) 0 (0)
- Needs assistance 6 (6.1) 4 (5.2) 3 (2.2) 7 (6.7)
- Fully dependent 92 (93.4) 73 (94.8) 133 (97.8) 97 (93.3)
Mobility dependencya, n (%)
- Independent 1 (1.0) 2 (2.6) 2 (1.5) 2 (1.9)
- Needs assistance 12 (12.4) 9 (11.7) 11 (8.3) 16 (15.5)
- Fully dependent 84 (86.6) 66 (85.7) 120 (90.2) 85 (82.5)
Non-advanced dementia (n = 65) (n = 61) (n = 167) (n = 110)
Age at time of death, unadjusted mean (SD) 87.1 (7.9) 87.5 (7.5) 85.7 (7.8) 86.9 (6.1)
Gender, female, unadjusted frequency, n (%) 47 (57.7) 36 (59.0) 113 (67.7) 73 (66.4)
Eating dependencya, n (%)
- Independent 6 (9.4) 13 (21.7) 33 (20.1) 28 (25.5)
- Needs assistance 37 (57.8) 30 (50.0) 97 (59.1) 61 (55.5)
- Fully dependent 21 (32.8) 17 (28.3) 34 (20.7) 21 (19.1)
Dressing dependencya, n (%)
- Independent 1 (1.6) 3 (5.2) 8 (4.8) 6 (5.6)
- Needs assistance 17 (27.0) 19 (32.8) 58 (34.9) 41 (38.0)
- Fully dependent 45 (71.4) 36 (62.1) 100 (60.2) 61 (56.5)
Mobility dependencya, n (%)
- Independent 13 (20.3) 6 (10.2) 29 (17.5) 14 (13.0)
- Needs assistance 18 (28.1) 28 (47.5) 57 (34.3) 39 (36.1)
- Fully dependent 33 (51.6) 25 (42.4) 80 (48.2) 55 (50.9)
Without dementia (n = 74) (n = 82) (n = 157) (n = 137)
Age at time of death, unadjusted mean (SD) 82.5 (12.2) 83.2 (9.6) 84.0 (10.9) 84.2 (10.2)
Gender, female, unadjusted frequency, n (%) 50 (67.6) 44 (53.7) 88 (56.1) 79 (57.7)
Eating dependencya, n (%)
- Independent 18 (25.0) 25 (31.6) 55 (35.5) 47 (35.6)
- Needs assistance 34 (47.2) 33 (41.8) 68 (43.9) 51 (38.6)
- Fully dependent 20 (27.8) 21 (26.6) 32 (20.6) 34 (25.8)
Dressing dependencya, n (%)
- Independent 3 (4.2) 11 (13.8) 14 (9.0) 21 (6.1)
- Needs assistance 25 (34.7) 25 (31.3) 63 (40.6) 103 (29.9)
- Fully dependent 44 (61.1) 44 (55.0) 78 (50.3) 220 (64.0)
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did not achieve better outcomes for residents without
dementia or with non-advanced dementia than for those
with advanced dementia. Hence, as was clear from the
primary trial analyses [5], the stepwise training of nurs-
ing home staff over a one-year period was not sufficient
to improve comfort in the final days of life, which might
be related to the intervention itself, the quality of its im-
plementation in several nursing homes, a possible mis-
match between the intervention and the primary
outcome, or a combination of these factors [5, 23]. For
instance, PACE Steps to Success was fully implemented
as intended only in 28 of the 37 intervention nursing
homes in terms of the number, order and timing of
training sessions; and all 6 steps were taught in the right
order and within 8 months. In seven other nursing
homes, the six steps were taught but not in the right
order and/or not within 8 months. In two nursing
homes, they only completed five steps. Further, the
adoption rates for the program materials (e.g. advance
care planning material for residents) varied between
countries but also fluctuated within countries [23].
While PACE Steps to Success might have addressed
essential domains of palliative care that have been widely
recommended for residents with and without dementia
(i.e. person-centered care, advance care planning, opti-
mal symptom assessment and management until the end
of life, education of and support for healthcare providers,
and support for family) [24–26], the sub-optimal imple-
mentation of the program in several nursing homes
might have attenuated its effects on residents’ comfort at
the end-of-life [23].
Regarding the secondary outcome, the PACE program
appeared to improve quality of care and dying in the last
month of life equally for those with dementia (regardless
of the stage) and those without dementia. Although
these findings need to be interpreted cautiously as this is
a secondary outcome, they are remarkable, as this pallia-
tive care program only had a limited number of
dementia-specific elements as part of the training [4].
However, the Quality of Dying in Long Term Care
(QOD-LTC) scale individual items that differed between
the intervention and control groups included ‘receiving
affectionate touch’, ‘keeping clothes and body clean’,
‘residents appearing to be at peace’, ‘being prepared to
Table 1 Characteristics of residents by subgroups (Continued)
TOTAL SAMPLE FOR THE SUBGROUP ANAL
YSIS
Baseline scores (T0) Post-intervention (T1 + T2)
Control Intervention Control Intervention
N = 238 N = 221 N = 460 N = 351
Mobility dependencya, n (%)
- Independent 4 (5.5) 14 (18.2) 22 (14.2) 25 (18.9)
- Needs assistance 29 (39.7) 24 (31.2) 55 (35.5) 42 (31.8)
- Fully dependent 40 (54.8) 39 (50.6) 78 (50.3) 65 (49.2)
Missing cases – Advanced dementia, baseline: age = 3; gender = 4; BANS-S = 3 | post-intervention measurements: age = 6; gender = 3; BANS-S = 3). Non-advanced
dementia, baseline: age = 6; gender = 5; BANS-S = 3 | post-intervention measurements: age = 6; gender = 6; BANS-S = 2). Without dementia, baseline: age = 3;
gender = 4; BANS-S = 7 | post-intervention measurements: age = 12; gender = 8; BANS-S = 7
Abbreviations: SD standard deviation, BANS-S Bedford Alzheimer Nursing Severity-Scale
a Measured using BANS-S one month before death (range 7–28). Higher scores indicate greater severity. Unadjusted frequencies
Table 2 Effects on comfort and quality of care and dying by subgroups
Comparison between the subgroups Subgroup differences in baseline-adjusted mean difference (95% CI) p-valuesc
Comfort in the last week of lifea
Advanced dementia vs Without dementia 2.1 (−0.9–5.1) 0.177
Non-advanced dementia vs Without dementia 2.7 (−0.4–5.9) 0.092
Advanced dementia vs Non-advanced dementia −0.6 (−3.8–2.5) 0.698
Quality of care and dying in the last month of lifeb
Advanced dementia vs Without dementia −0.6 (−4.1–2.9) 0.741
Non-advanced dementia vs Without dementia −1.5 (−5.2–2.2) 0.428
Advanced dementia vs Non-advanced dementia 0.9 (−2.8–4.6) 0.632
All mean total scores and p-values are cluster-adjusted
Abbreviations: CAD-EOLD Comfort Assessment in Dying–End of Life in Dementia, QOD-LTC Quality of Dying in Long Term Care, CI confidence intervals
a Comfort in the last week of life was measured using CAD-EOLD scale (total scores range 14–42). Higher scores indicate better comfort
b Quality of care and dying in the last month of life was measured using QOD-LTC scale (total scores range 11–55). Higher scores indicate better quality of care
and dying
c Subgroup differences in the estimated baseline-adjusted mean differences between intervention and control groups post-intervention (group x time x
dementia interaction)
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die’, and ‘maintaining their sense of humor’. [5] Such
quality of care and dying topics are not directly related
to the cognitive, functional or other specific problems in
dying nursing home residents with dementia [9, 27],
which might explain why the effects did not differ be-
tween the subgroups.
Overall, our study implies that such a generalist and
non-disease-specific palliative care program for nursing
homes has the potential to improve quality of care and
dying in the last month of life for both residents with
and without dementia, though this finding requires fur-
ther investigation and effects were only medium-sized
[5]. Nevertheless, our study provides crucial insight for
future developers of palliative care programs aiming to
improve quality of life and dying of nursing home resi-
dents with and without dementia. A broad palliative care
training program, such as PACE Steps to Success, can
be a useful starting point for further improvement in
palliative care in nursing homes. However, as in the pri-
mary trial analyses [5], this subgroup analysis empha-
sizes that this program needs to be developed further for
both residents with and without dementia, e.g. to effect-
ively promote comfort in the last days of life, either in
terms of its components or the implementation pro-
cesses in practice [26, 28]. Especially for dementia, as
end-of-life symptoms might be very specific compared
with other diseases, a strong collaboration among ex-
perts in research and practice in palliative care and de-
mentia seems important [11, 26]. Future research
evaluating palliative care programs should take into ac-
count dementia as an important subgroup, as prevalence
is high in all countries, and nursing home residents die
at varying stages of dementia [3].
Conclusion
This subgroup analysis showed that the effects of PACE
Steps to Success did not differ between residents with
advanced, non-advanced and no dementia. These find-
ings suggest that this program did not improve comfort
in the last week of life for residents with or without de-
mentia, but it appeared to improve quality of care and
dying in the last month of life equally for residents with
dementia (regardless of the stage) and without dementia.
A generalist and non-disease-specific palliative care
training program, such as PACE Steps to Success, can
be a useful starting point for future development of pal-
liative care programs in nursing homes. However, PACE
Steps to Success needs to be developed further, so that it
can effectively improve the quality of life and dying of
both residents with and without dementia, e.g. by inte-
grating components to improve residents’ comfort at the
end of life.
Table 3 Cluster-adjusted mean scores and differences by subgroups
Individual subgroups Baseline scores (T0) Post-intervention scores (T1 + T2) d Baseline-adjusted mean difference
intervention versus control group
post-intervention










Comfort in the last week of lifea
Advanced dementia n = 99 n = 78 n = 136 n = 104 0.2
91 30.6 74 30.8 131 30.3 97 30.7
Non-advanced
dementia
n = 65 n = 61 n = 167 n = 110 0.8
60 30.0 57 30.0 157 31.0 102 31.8
Without dementia n = 74 n = 82 n = 157 n = 137 −1.9
70 29.7 75 30.6 146 31.3 128 30.2
Quality of care and dying in the last month of lifeb
Advanced dementia n = 99 n = 78 n = 136 n = 104 3.6
97 38.1 75 37.1 135 38.0 103 40.6
Non-advanced
dementia
n = 65 n = 61 n = 167 n = 110 2.7
65 38.4 59 38.3 163 39.5 104 42.2
Without dementia n = 74 n = 82 n = 157 n = 137 4.2
74 41.2 78 39.3 152 39.8 133 42.2
All mean differences between groups post-intervention are cluster and baseline adjusted
Abbreviations: CAD-EOLD Comfort Assessment in Dying – End of Life in Dementia, QOD-LTC Quality of Dying in Long Term Care
a Comfort in the last week of life was measured using CAD-EOLD scale (total scores range 14–42). Higher scores indicate better quality of dying
b Quality of care and dying in the last month of life was measured using QOD-LTC scale (total scores range 11–55). Higher scores indicate better quality of
end-of-life care
c Total scores are averages per subscale multiplied by total number of items. Cases with missing data on more than 50% of items per subscale were excluded
from the calculation of the total scale scores
d Post intervention measurements collected for residents at T1 (=month 13) and T2 (=month 17)
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Abbreviations
ADL: Activities of Daily Living; BANS-S: Bedford Alzheimer Nursing Severity-
Scale; CAD-EOLD: Comfort Assessment in Dying–End-of-Life in Dementia;
CI: Confidence interval; CPS: Cognitive Performance Scale; QOD-LTC: Quality
of Dying in Long Term Care; GDS: Global Deterioration Scale; GP: General
practitioners; RCT: Randomized controlled trial
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